New drug formulation tested to make lymphoma transplants safer
Disease control
Recruiting now
This study is testing whether a new formulation of the chemotherapy drug carmustine causes fewer side effects than the standard version when used as part of the high-dose chemotherapy given before a stem cell transplant. The trial will enroll about 49 adults with Hodgkin or non-H…
Phase: PHASE2 • Sponsor: VIVUS LLC • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC